Search Results - "Ramkumar, Dipak B"

Refine Results
  1. 1

    Patient-reported outcomes after revision of metal-on-metal total bearings in total hip arthroplasty by Mata-Fink, Ana, MD, MS, Philipson, Daniel J., MD, Keeney, Benjamin J., PhD, Ramkumar, Dipak B., MD, Moschetti, Wayne E., MD, MS, Tomek, Ivan M., MD, FRCSC

    Published in The Journal of arthroplasty (01-04-2017)
    “…Abstract Background Failure of metal-on-metal (MOM) total hip arthroplasty (THA) bearings is often accompanied by an aggressive local reaction associated with…”
    Get full text
    Journal Article
  2. 2

    Excess Opioid Medication and Variation in Prescribing Patterns Following Common Orthopaedic Procedures by Sabatino, Matthew J., Kunkel, Samuel T., Ramkumar, Dipak B., Keeney, Benjamin J., Jevsevar, David S.

    “…Postoperative pain management in orthopaedic surgery accounts for a substantial portion of opioid medications prescribed in the United States. Understanding…”
    Get full text
    Journal Article
  3. 3

    Paget Disease of Bone by Al-Rashid, Mamun, MD, FRCS (Orth), Ramkumar, Dipak B., MD, Raskin, Kevin, MD, Schwab, Joseph, MD, MS, Hornicek, Francis J., MD, PhD, Lozano-Calderón, Santiago A., MD, PhD

    Published in The Orthopedic clinics of North America (01-10-2015)
    “…The current understanding of Paget disease of bone (PDB) has vastly changed since Paget described the first case in 1877. Medical management of this condition…”
    Get full text
    Journal Article
  4. 4
  5. 5

    The Efficacy of Tranexamic Acid in Total Hip Arthroplasty: A Network Meta-analysis by Fillingham, Yale A., Ramkumar, Dipak B., Jevsevar, David S., Yates, Adolph J., Shores, Peter, Mullen, Kyle, Bini, Stefano A., Clarke, Henry D., Schemitsch, Emil, Johnson, Rebecca L., Memtsoudis, Stavros G., Sayeed, Siraj A., Sah, Alexander P., Della Valle, Craig J.

    Published in The Journal of arthroplasty (01-10-2018)
    “…Tranexamic acid (TXA) is an antifibrinolytic agent commonly used to reduce blood loss in total hip arthroplasty (THA). The purpose of our study was to evaluate…”
    Get full text
    Journal Article
  6. 6
  7. 7

    The Safety of Tranexamic Acid in Total Joint Arthroplasty: A Direct Meta-Analysis by Fillingham, Yale A., Ramkumar, Dipak B., Jevsevar, David S., Yates, Adolph J., Shores, Peter, Mullen, Kyle, Bini, Stefano A., Clarke, Henry D., Schemitsch, Emil, Johnson, Rebecca L., Memtsoudis, Stavros G., Sayeed, Siraj A., Sah, Alexander P., Della Valle, Craig J.

    Published in The Journal of arthroplasty (01-10-2018)
    “…Tranexamic acid (TXA) is effective in reducing blood loss in total joint arthroplasty (TJA), but concerns still remain regarding the drug's safety. The purpose…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Pharmacologic Hemostatic Agents in Total Joint Arthroplasty—A Cost-Effectiveness Analysis by Ramkumar, Dipak B., Ramkumar, Niveditta, Tapp, Stephanie J., Moschetti, Wayne E.

    Published in The Journal of arthroplasty (01-07-2018)
    “…Total knee and hip arthroplasties can be associated with substantial blood loss, affecting morbidity and even mortality. Two pharmacological antifibrinolytics,…”
    Get full text
    Journal Article
  10. 10

    Risk factors for detectable metastatic disease at presentation in Ewing sarcoma – An analysis of the SEER registry by Ramkumar, Dipak B., Ramkumar, Niveditta, Miller, Benjamin J., Henderson, Eric R.

    Published in Cancer epidemiology (01-12-2018)
    “…•Patients age 24+ face 2x increased risk of presenting with metastatic EFT (vs <11 y.o).•Large, axial tumors association with 2-3x risk of metastatic EFT at…”
    Get full text
    Journal Article
  11. 11

    Development of machine learning model algorithm for prediction of 5‐year soft tissue myxoid liposarcoma survival by Kamalapathy, Pramod N., Ramkumar, Dipak B., Karhade, Aditya V., Kelly, Sean, Raskin, Kevin, Schwab, Joseph, Lozano‐Calderón, Santiago

    Published in Journal of surgical oncology (01-06-2021)
    “…Background Predicting survival in myxoid liposarcoma (MLS) patients is very challenging given its propensity to metastasize and the controversial role of…”
    Get full text
    Journal Article
  12. 12

    Management of limb length discrepancy after bone sarcoma resection about the knee in the skeletally immature by Kelly, Sean P, Ramkumar, Dipak B, Crawford, Brooke, Lozano-Calderon, Santiago A, Gebhardt, Mark C, Anderson, Megan E

    Published in Journal of pediatric orthopaedics. B (01-09-2024)
    “…Patients with bone sarcomas increasingly choose limb salvage. This can lead to issues with limb length discrepancy (LLD) for the skeletally immature. We…”
    Get full text
    Journal Article
  13. 13

    Oncological and Functional Outcomes in Joint-sparing Resections of the Proximal Femur for Malignant Primary Bone Tumors by Ramkumar, Dipak B., Kelly, Sean P., Ramkumar, Niveditta, Ercolano, Lisa B., Lozano-Calderon, Santiago, Gebhardt, Mark C., Anderson, Megan E.

    Published in Journal of pediatric orthopaedics (01-09-2021)
    “…Background Joint-sparing resections (JSR) of the proximal femur allow for preservation of the proximal femoral growth plate and native hip joint, but whether…”
    Get full text
    Journal Article
  14. 14

    Sclerotherapy for Aneurysmal Bone Cysts: Scale for Response by Ramkumar, Dipak B., Ercolano, Lisa B., Allar, Benjamin G., Miller, Patricia E., Padua, Horacio, Anderson, Megan E.

    Published in Journal of pediatric orthopaedics (01-08-2021)
    “…The objective of this study was to develop a response scale for aneurysmal bone cysts (ABCs) treated with sclerotherapy and determine its inter-rater…”
    Get full text
    Journal Article
  15. 15

    Sclerostin immunohistochemical staining in surgically treated giant cell tumor of bone by Kelly, Sean P., Ramkumar, Dipak B., Peacock, Zachary S., Newman, Erik T., Venrick, Connor, Lozano‐Calderon, Santiago A., Raskin, Kevin A., Chebib, Ivan, Schwab, Joseph H.

    Published in Journal of surgical oncology (01-09-2022)
    “…Background Giant cell tumor of bone (GCTB) is a destructive lesion with a high potential for recurrence. RANK‐ligand targeted therapy has provided promising,…”
    Get full text
    Journal Article
  16. 16

    Adjunct diagnostic strategies in improving diagnostic yields in image‐guided biopsies of musculoskeletal neoplasms—A cost‐effectiveness analysis by Ramkumar, Dipak B., Kelly, Sean P., Ramkumar, Niveditta, Gyftopoulos, Soterios, Raskin, Kevin A., Lozano‐Calderon, Santiago A., Chang, Connie Y.

    Published in Journal of surgical oncology (01-12-2021)
    “…Background Routine use of adjunct intraprocedural fresh frozen biopsy (FFP) or point‐of‐care (POC) cytology at the time of image‐guided biopsy can improve…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Development and evaluation of a connective tissue phantom model for subsurface visualization of cancers requiring wide local excision by Samkoe, Kimberley S, Bates, Brent D, Tselepidakis, Niki N, DSouza, Alisha V, Gunn, Jason R, Ramkumar, Dipak B, Paulsen, Keith D, Pogue, Brian W, Henderson, Eric R

    Published in Journal of biomedical optics (01-12-2017)
    “…Wide local excision (WLE) of tumors with negative margins remains a challenge because surgeons cannot directly visualize the mass. Fluorescence-guided surgery…”
    Get full text
    Journal Article
  19. 19

    Sclerostin Immunohistochemical Staining in Aggressive Maxillofacial Giant Cell Lesions: Initial Results and Potential Therapeutic Target by Kelly, Sean P., Ramkumar, Dipak B., Lozano-Calderon, Santiago A., Newman, Erik T., Raskin, Kevin A., Chebib, Ivan, Schwab, Joseph H., Peacock, Zachary S.

    Published in The Journal of craniofacial surgery (01-05-2022)
    “…Introduction: Maxillofacial (MF) giant cell lesions (GCLs) are benign, often locally aggressive lesions with potential for recurrence. Systemic treatments have…”
    Get full text
    Journal Article
  20. 20